Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
244
days
PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma
Authors
Shuling Chen; Yuanqi Wang; Jingying Chen; Wenxuan Xie; Jianyu Chen; Guanrui Liao; Xiaoxue Ren; Kai Lei; Yuting Zhang; Shu Wang; Ye Yang; Youmei Kang; Qiaoyi Chen; Yixi Wen; Jiaming Lai; Pengyuan Yang; Shunli Shen; Shaoqiang Li; Johnson Yiu-Nam Lau; Changjun Yin; Ming KuangShow moreShow less
Affiliations
Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Institute of Precision Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Department of Oncology, Cancer Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Department of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100101, China; Faculty of Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR; Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, GermanyShow moreShow less
252
days
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial
Authors
Zhiyuan Xu; Can Hu; Litao Yang; Pengfei Yu; Yanqiang Zhang; Jiahui Chen; Guoliang Zheng; Xiaodong Chen; Tao Zhang; Weiyang He; Xiangyu Meng; Panpan Yu; Yian Du; Xiaowen Liu; Youdong Liu; Yongxiang Wang; Xiaoxiao Wu; Siwei Pan; Ruolan Zhang; Shengjie Zhang; Zhirong Xiong; Wei Sun; Chuanxin Dong; Jiajun Liu; Yuexian Wu; Xiangdong ChengShow moreShow less
Affiliations
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Department of Gastric Surgery, Liaoning Cancer Hospital, Shenyang, Liaoning, China; Department of Gastric Surgery, Sichuan Cancer Hospital, Chengdu, Sichuan, China; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou 310022, China; Medical Affairs, BeOne Medicines (Beijing) Co., Ltd., Beijing, ChinaShow moreShow less
258
days
Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms
Authors
Jeremy Wen; Anitria Cotton; Rashid Mehmood; Man Mohan; Trent Hall; Amber L. Broadhurst; Kevin Zhang; Yunusa Olufadi; Guolian Kang; Bridget Marcellino; John Mascarenhas; Ronald Hoffman; Laura J. Janke; Sandeep Gurbuxani; Gerard M. McGeehan; John D. CrispinoShow moreShow less
Affiliations
Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA; Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA; Tisch Cancer Institute, Icahn School of Medicine, New York, NY 10029, USA; Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA; Section of Hematopathology, University of Chicago, Chicago, IL 60637, USA; Syndax Pharmaceutics, Inc., New York, NY 10017, USAShow moreShow less
338
days
GABA promotes resistance to immunotherapy in patients with TLS-positive tumors
Authors
Isaias Hernández-Verdin; Anne Calvez; Cheng-Ming Sun; Antoine Bougoüin; Pierre Hirt; Eric Pinaud; Matthew J. Smith; Craig E. Wheelock; Virginie Verkarre; Yann-Alexandre Vano; Lucie Garnier; Théo Bouloudani; Guilhem Pupier; Dahbia Djaroun; Christian Wu; Asmat Ullah; Lucile Vanhersecke; Alban Bessede; Jean-Philippe Guegan; Laurence Albiges; Sylvère Durand; Guido Kroemer; Agusti Alentorn; Antoine Italiano; Stéphane Oudard; Catherine Sautès-Fridman; Wolf Herman FridmanShow moreShow less
Affiliations
Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, 75006 Paris, France; Equipe labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France; Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, 75013 Paris, France; Laboratoire Contrôle de la Réponse Immune B et des Lymphoproliférations (CRIBL), CNRS Unité Mixte de Recherche 7276, INSERM Unité 1262, Université de Limoges, Limoges, France; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, 171 64 Stockholm, Sweden; Département de Pathologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris - Paris Centre, 75015 Paris, France; Université Paris Cité, 75006 Paris, France; Département d’Oncologie Médicale, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris - Paris Centre, 75015 Paris, France; Département d’Oncologie Médicale, Hôpital Foch, Suresnes France, Université de Versailles-Saint-Quentin-en-Yvelines, Versailles, France; Departement de Biopathologie, Institut Bergonié, Bordeaux, France; Explicyte, Bordeaux, France; Gustave Roussy, Université Paris-Saclay, Villejuif, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Department of Neurology-2, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France; Departement d’Oncologie Médicale, Institut Bergonié, Bordeaux, France; DITEP, Gustave Roussy, Villejuif, France; Université de Bordeaux, Bordeaux, France; PARCC, INSERM, Equipe Labellisée Ligue contre le Cancer, 75015 Paris, FranceShow moreShow less
425
days
Spatial multi-omics landscape of colorectal cancer macro- and micrometastases
Authors
Yang Liu; Akshaya S. Jadhav; Yuwen Pan; Jianlong Liao; Isha Khanduri; Yunhe Liu; Riham Katkhuda; Wei Lu; Kyung Serk Cho; Zhimin Tong; Tieling Zhou; Kangyu Lin; Baohua Sun; Mei Jiang; Sharia D. Hernandez; Idania Carolina Lubo Julio; Patrick Brennan; Guangsheng Pei; Kai Yu; Yibo Dai; Tian Chu; Fuduan Peng; Khaja Khan; Saxon Rodriguez; Ling Xia; Youming Guo; Alicia Mejia; Sean W. Barnes; Ou Shi; Shreeya Indulkar; Alaa M.T. Mohamed; Natalie Wall Fowlkes; Timothy Newhook; Yun Shin Chun; Van K. Morris; David Menter; Dadi Jiang; John Paul Shen; Ryan Sun; Jean-Nicolas Vauthey; Ruoyan Li; Humam Kadara; Luisa M. Solis Soto; Scott Kopetz; Linghua Wang; Dipen MaruShow moreShow less
Affiliations
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of GI Radiation Oncology, Division of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for Cellular Language Intelligence, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USAShow moreShow less
300
days
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
Authors
Jun Liao; Wenxiu Yao; Yan Yu; Anlin Li; Jie Huang; Xingya Li; Longhua Sun; Yongchang Zhang; Yongsheng Wang; Xiujuan Qu; Jun Zhao; Haiyong Wang; Weitao Zhuang; Liyang Hu; Xueyuan Chen; Lanlan Pang; Mengjuan Yang; Zexin Chen; Yaxiong Zhang; Ting Li; Wenyan Yu; Yiming Zeng; Jing Li; Ritesh Kataria; Gideon Blumenthal; Omobolaji Akala; Yanjun Liu; Yuping Shen; Junyou Ge; Shaodong Hong; Yunpeng Yang; Li Zhang; Wenfeng FangShow moreShow less
Affiliations
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Thoracic Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China; Department of Medical Oncology, Digestive and Urinary Unit, Hunan Cancer Hospital, Changsha, China; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China; Department of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China; Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Department of Thoracic Oncology, the Cancer Center of the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China; Guangdong Research Center of Organoid Engineering and Technology, Guangzhou, China; Merck & Co., Inc., Rahway, NJ, USA; Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days